Skip to main content
Clinical Trials/NCT03606863
NCT03606863
Unknown
Phase 3

A RANDOMIZED, CONTROLLED, CLINICAL TRIAL TO COMPARE PERIPHERAL PARENTERAL NUTRITION (PeriOlimel N4-E) VERSUS CONVENTIONAL FLUID THERAPY IN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN COLORECTAL CANCER SURGERY.

Antonio Arroyo Sebastian1 site in 1 country200 target enrollmentOctober 2016

Overview

Phase
Phase 3
Intervention
Perioperative peripheral parenteral nutrition
Conditions
Colon Cancer
Sponsor
Antonio Arroyo Sebastian
Enrollment
200
Locations
1
Primary Endpoint
morbi-mortality
Last Updated
7 years ago

Overview

Brief Summary

Assess if administration of early nutrition support with Perioperative Peripheral Nutrition (PeriOliclimonel) N4-E) in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery (ERAS) Protocol improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy.

Detailed Description

The main objective is to determine if perioperative nutritional support with PeriOlimel N4-E, that reaches nutritional requirements of ERAS protocol for colorectal cancer surgery patients, can improve nutritional status so it decreases postoperative complications, hospital length of stay and costs, compared to conventional fluid therapy administration since patients receive oral nutrition at day 3-5.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
April 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Antonio Arroyo Sebastian
Responsible Party
Sponsor Investigator
Principal Investigator

Antonio Arroyo Sebastian

Principal Investigator

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Eligibility Criteria

Inclusion Criteria

  • scheduled colorectal cancer surgery

Exclusion Criteria

  • Emergency surgery
  • Distant metastasis
  • Patient´s refusal to participate
  • Allergy or hypersensitivity to egg or soy protein
  • Advanced kidney or hepatic impairment
  • Severe bleeding disorders
  • Congenital abnormalities of amino acid metabolism
  • Hyperlipidemia and severe or difficult to control hyperglycemia

Arms & Interventions

Perioperative peripheral parenteral nutrition

Perioperative peripheral parenteral nutrition during 4 days

Intervention: Perioperative peripheral parenteral nutrition

Outcomes

Primary Outcomes

morbi-mortality

Time Frame: 30 days

Early Peripheral Parenteral Nutrition in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery Protocol to improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy

Study Sites (1)

Loading locations...

Similar Trials